BioSim considers that the new legal regulations may be an opportunity to promote the growth of the national pharmaceutical industrial fabric that not only contributes to alleviating the effects of future crises, but also acts as a scientific and economic engine for Spain.
recently published
Horizon scanning
Jan 31 2024
Early Treatment: the role of biosimilars
18 2023 December
